Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFIRI with or without zibotentan in metastatic colorectal cancer after oxaliplatin failure
2009-012151-23Phase 2Completed
- Sponsor
- Cardiff University
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of zibotentan in colorectal cancer (CRC) (2 arms), sponsored by Cardiff University. Primary endpoint: Progression-free survival. Started Sep 2009; status: completed.
02
Drugs
zibotentan
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2009-012151-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012151-23.